Plain-English translation of NCT06023589 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new injectable medication called to see if it can help children with severe asthma that isn't well controlled by their current medicines. About 231 children ages 5 to 12 will participate. Half will receive the medication as weekly injections under the skin for one year, and half will receive a placebo (a dummy injection) so doctors can fairly compare how well the treatment works.
Many children with severe asthma continue to have symptoms and flare-ups even when taking multiple strong medications. Researchers believe this medication might work differently to better control asthma and reduce these serious breathing episodes.
You likely qualify if…
You likely don't qualify if…
You will first have a 4–6 week screening period where doctors confirm your asthma diagnosis and that your symptoms aren't controlled well enough. Then you'll be randomly assigned to receive either the medication or a placebo as an injection under the skin once a week for 52 weeks. You'll have regular clinic visits to check how well the treatment is working, provide breath tests, and report any side effects. After the year-long treatment period, there's a 12-week follow-up, and you may have the option to continue receiving the active medication for another 2 years.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
United States